JHIU
GBT

Janus Henderson Investors US’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Janus Henderson Investors US’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$29.7M Sell
806,283
-267,055
-25% -$6.73M 0.02% 540
2016
Q4 		$15.5M Sell
1,073,338
-143,567
-12% -$2.52M 0.01% 662
2016
Q3 		$28.1M Sell
1,216,905
-32,781
-3% -$625K 0.02% 536
2016
Q2 		$20.7M Buy
1,249,686
+471,229
+61% +$9.51M 0.02% 567
2016
Q1 		$12.3M Buy
778,457
+79,073
+11% +$1.41M 0.01% 639
2015
Q4 		$22.6M Buy
+699,384
New +$30.3M 0.02% 581

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Investors US's GBT Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Global Blood Therapeutics, Inc. (GBT) stake by 25% in Q1 2017, selling an estimated $6.73M and leaving 806,283 shares worth $29.7M. The position accounts for 0.02% of the portfolio, ranked #540.

Janus Henderson Investors US first reported a position in GBT in Q4 2015 and has held it in 6 quarters since. 116 funds tracked by Wall St. Rank hold GBT as of Q1 2017.

  • Janus Henderson Investors US held 806,283 shares of Global Blood Therapeutics, Inc. worth $29.7M as of Q1 2017.
  • Janus Henderson Investors US sold 267,055 Global Blood Therapeutics, Inc. shares in Q1 2017, an estimated $6.73M.
  • Global Blood Therapeutics, Inc. made up 0.02% of Janus Henderson Investors US's portfolio in Q1 2017, its #540 holding.
  • Janus Henderson Investors US first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and has held it in 6 quarters since.
  • 116 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.